Summary:
Phase 3 72 hour stay study to compare the efficacy and duration of the following:
- analgesia following local administration of HTX-011 with saline placebo during the first 72 hours following unilateral open inguinal herniorrhaphy.
- analgesia for HTX-011 with bupivacaine HCl without epinephrine during the first 72 hours following surgery in this study population.
- HTX-011 with saline placebo and bupivacaine HCl without epinephrine on opioid load during the first 72 hours following surgery in this study population.
- To assess the safety and tolerability of HTX-011 in this study population.
Inclusion Criteria:
Must be male or female, and ≥18 years of age at screening.
Is scheduled to undergo a unilateral open inguinal herniorrhaphy with mesh under general anesthesia.
Must be willing to stay at the surgery center for 72 hours.
Qualified Participants May Receive:
If you qualify and complete the entire study you may be compensated up to $1,400.00